Some studies found no statistically significant difference of OS between DLL3 low and high expressing tumors (3, 15), whereas Regzedmaa et al. found that high expression of DLL3 assessed on chemonaive SCLC correlated significantly with poorer patient outcomes (p = <0.001) (8). The gene discussed is DLL3; the disease is small cell lung carcinoma.